Founded

Address

Lilly Ventures
115 W. Washington Street
South Tower 1680
Indianapolis, IN 46204
United States

Open map


Recent investment activity

KANDO id: 30096

Corporate information

Registration country

Funding rounds

Top investment portfolio themes

Actual initial investment stage
N/A (1)

Investment activity status
Active investor

Selected investments

Displaying 1 - 25 of 36
Profile Country Date Sort descending Funding
GlobeImmune Inc Biopharmaceuticals company. N/A
RelayHealth Corp N/A
Trinity Biosystems Inc Developer of a platform for the delivery of peptides across intact mucosal surfaces. N/A
IRX Therapeutics Inc N/A
Kanisa Pharmaceuticals Inc Biopharmaceutical company employing a targeted approach to the diagnosis and treatment of cancer. N/A
Anthera Pharmaceuticals Inc N/A
Intradigm Corp N/A
InCube Ventures LLC Life science venture capital firm focused on investing in extraordinary innovations that solve unmet clinical needs for large patient populations. N/A
Forma Therapeutics Inc N/A
CGI Pharmaceuticals Inc A biopharmaceutical company developing small molecule therapeutics for multiple oncology and immunology-based indications. N/A
XenoPort Inc N/A Initial investment
Serenex Inc Oncology-focused drug development company N/A
Conforma Therapeutics Corp Novel drugs company for the selective treatment of cancer. N/A
MedManage Systems Inc Online drug sampling provider N/A
Aileron Therapeutics Inc Developing a breakthrough proprietary peptide technology platform N/A
Hydra Biosciences Inc N/A
Bayhill Therapeutics A biopharmaceutical company focused on the translation of research into therapeutics for the treatment of autoimmune diseases. N/A
Viamet Pharmaceuticals Inc N/A
Remon Medical Technologies Inc Medical device company providing smart, miniature implants. Series C
Avid Radiopharmaceuticals Inc Series A
InnoCentive Inc Series A
Cabrellis Pharmaceuticals Corp Development of important therapies for the treatment of cancer Series A
Protagonist Therapeutics Inc Biotechnology company dedicated to the discovery of novel peptide and small molecule compounds. Series A
Fluidigm Corp Developer and manufacturer of microfluidic systems for markets in the life science and agricultural biotechnology industries. Series E
Cylene Pharmaceuticals Inc Clinical stage private company developing small molecule drugs against newly validated cancer targets. Series C

Past employees

Selected Products / Customers

Financials